SYSTANE Ultra from Alcon Inc. - Dry eye relief built for digital days

By Julian Reed, ad hoc news Accessories & Components Desk. Reviewed July 01, 2026, 12:16 PM ET. Details in the imprint.

SYSTANE Ultra Lubricant Eye Drops sit next to the register in a lot of US pharmacies, a small green-and-blue box promising relief for tired, burning eyes. One tester described the first drops after a long Zoom day as "like cool water on sandpaper." For Alcon, this bottle is a quiet workhorse in the dry eye aisle.

Formulation built for screen-heavy lives

Alcon positions SYSTANE Ultra as a high-performance lubricant eye drop for people with dry eye symptoms from environmental conditions or digital device use, using polyethylene glycol (PEG) 400 and propylene glycol as active ingredients. Official product page The drops are designed to restore the tear film and reduce friction on the corneal surface, which many patients feel as burning or grittiness.

In the US, SYSTANE Ultra is sold over the counter in 10 mL and 15 mL bottles, with typical retail prices between about $12 and $18 depending on size and retailer. CVS product listing Walking into a Walgreens or CVS, the SYSTANE line usually occupies a full shelf segment, with Ultra framed as the go-to option for moderate, recurring symptoms.

How SYSTANE Ultra is positioned

Alcon’s dry eye portfolio today spans products like SYSTANE Ultra, SYSTANE Complete, SYSTANE Gel Drops and SYSTANE Hydration PF, each tuned to different symptom profiles and patient preferences. Alcon dry eye overview Ultra is marketed as a balance of comfort and duration, aimed at users who don’t necessarily have severe disease but feel daily strain.

In investor presentations, Alcon management, including CEO David Endicott, has repeatedly highlighted dry eye and ocular health as growth segments within its Vision Care division, driven in part by more time spent on digital screens and aging demographics. Alcon earnings presentation SYSTANE Ultra sits near the center of that trend, alongside contact lens solutions and specialty drops.

Usage, comfort and first-hand feel

For US consumers, the instructions are straightforward: one or two drops in the affected eye as needed throughout the day, with the usual advice to remove contact lenses before using and wait at least 10 minutes before reinsertion. FDA label for lubricant drops The liquid itself feels slightly thicker than simple saline, but still clear and quick to spread across the eye surface.

In a practical sense, what many users notice is that the burning and foreign-body sensation eases within a minute or two. In a small clinic observation, an optometrist in Ohio described patients "opening their eyes wider after the second or third blink" once the tear film stabilizes. That kind of everyday relief is what keeps SYSTANE Ultra in handbags and desk drawers rather than just medicine cabinets.

Regulatory and competitive landscape

Lubricant eye drops like SYSTANE Ultra are regulated in the US as over-the-counter drugs, and formulations with PEG 400 and propylene glycol have long-standing FDA monograph support, which gives larger manufacturers room to create branded variants with different polymers and preservatives. FDA OTC monograph Within that framework, Alcon competes directly with Bausch + Lomb, Allergan’s Refresh line and private-label store brands.

Alcon’s differentiation with Ultra comes from its proprietary polymer system designed to enhance the tear film and extend retention time on the ocular surface, which the company highlights in customer-facing materials and professional education for eye care providers. Optometry trade coverage In practice, that means fewer reapplications during a day of work, a detail clinicians often mention to patients who struggle to remember frequent dosing.

Alcon context and stock lens

Alcon Inc. is best known on Wall Street for its surgical ophthalmology franchise, but OTC products like SYSTANE Ultra add recurring, broadly distributed revenue from drugstores, supermarkets, and online marketplaces in the US and globally. Alcon annual report For investors, dry eye and ocular health sit inside the company’s Vision Care segment alongside contact lenses.

SYSTANE Ultra may not move the needle on its own, but the broader SYSTANE portfolio supports Alcon Inc. stock (NYSE: ALC) by anchoring a stable, high-margin OTC category that complements its surgical and device businesses.

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.